SCHEMBL3789274

SCHEMBL3789274

CCOc1ccc(N)cc1-c1cccc(N)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.51
MAPT P10636 3/20 0.51
TP53 P04637 2/20 0.51
GAA P10253 2/20 0.51
CYP3A4 P08684 1/20 0.51
PTGDR2 Q9Y5Y4 1/20 0.51
MAP4K4 O95819 1/20 0.44
ALDH1A1 P00352 3/20 0.43
MEN1 O00255 2/20 0.43
POLB P06746 2/20 0.43
KMT2A Q03164 2/20 0.43
HPGD P15428 1/20 0.43
MAPK1 P28482 1/20 0.43
HSD17B10 Q99714 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
DHFR P00374 3/20 0.42
FYN P06241 1/20 0.42
CREBBP Q92793 1/20 0.41
MAOA P21397 1/20 0.41
PTPRC P08575 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3789504 0.88 PTGDR2 (0.65) KDM4EMAPTTP53GAACYP3A4
SCHEMBL3793105 0.87 PTPRC (0.55) KDM4EMAPTTP53GAACYP3A4
SCHEMBL3790341 0.87 MAPT (0.51) KDM4EMAPTTP53GAACYP3A4
SCHEMBL3780933 0.84 MAPT (0.56) KDM4EMAPTTP53GAACYP3A4
SCHEMBL3787533 0.82 TP53 (0.50) KDM4EMAPTTP53GAACYP3A4
SCHEMBL3789262 0.81 FYN (0.51) KDM4EMAPTGAACYP3A4PTGDR2
SCHEMBL7758589 0.80 MAOA (0.48) KDM4EMAPTCYP3A4PTGDR2MAP4K4
SCHEMBL3785868 0.80 MAPT (0.56) KDM4EMAPTTP53GAACYP3A4
SCHEMBL3786511 0.80 MAOB (0.55) MAPTGAAPTGDR2MAPK1L3MBTL1
SCHEMBL12493625 0.79 AGPAT2 (0.52) KDM4EMAPTTP53GAAPTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 KDM4E 2606/4885MAPT 3312/4885TP53 2819/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.